Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
- Conditions
- Prostate Cancer
- First Posted Date
- 2020-05-28
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT04404894
- Locations
- 🇺🇸
Urology Centers of Alabama, Homewood, Alabama, United States
🇺🇸VA Long Beach Healthcare System, Long Beach, California, United States
🇺🇸Manatee Medical Research Institute, Bradenton, Florida, United States
EndoPredict® Extended Endocrine Trial (EXET)
- Conditions
- Primary Invasive Breast Cancer
- Interventions
- Other: Observational
- First Posted Date
- 2019-07-12
- Last Posted Date
- 2022-05-17
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 855
- Registration Number
- NCT04016935
- Locations
- 🇺🇸
UPMC Memorial, York, Pennsylvania, United States
🇺🇸AON Hematology Oncology Clinic, Baton Rouge, Louisiana, United States
🇺🇸Allegheny Health Network, Pittsburgh, Pennsylvania, United States
A Registry for Hereditary Cancer Risk Assessment and Genetic Testing
- Conditions
- Prostate Cancer
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2020-11-05
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 255
- Registration Number
- NCT04015102
- Locations
- 🇺🇸
Associated Medical Professionals of New York, Syracuse, New York, United States
🇺🇸Associated Urologists of North Carolina, Raleigh, North Carolina, United States
🇺🇸Urologic Specialists of Northwest Indiana, Merrillville, Indiana, United States
Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing
- Conditions
- Prostate Cancer
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 774
- Registration Number
- NCT03511235
- Locations
- 🇺🇸
Kar Urology, Orange, California, United States
🇺🇸Golden Gate Urology, San Francisco, California, United States
🇺🇸University of Michigan Urology Cancer Center, Ann Arbor, Michigan, United States
Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Diagnostic Test: Prolaris Testing
- First Posted Date
- 2017-09-25
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 524
- Registration Number
- NCT03290508
- Locations
- 🇺🇸
Urology Group of Florida, Delray Beach, Florida, United States
🇺🇸A.M.P. Radiation Oncology, Syracuse, New York, United States
🇺🇸Lehigh Valley Health Network, Allentown, Pennsylvania, United States
Endometriosis Biomarker Discovery Study
- Conditions
- EndometriosisChronic Pelvic Pain
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2017-09-05
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Registration Number
- NCT03272360
Prospective Prolaris Value and Efficacy
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: Prolaris
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2022-06-13
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 1511
- Registration Number
- NCT03152448
- Locations
- 🇺🇸
VA San Diego Healthcare System, San Diego, California, United States
🇺🇸VA Connecticut Healthcare System, West Haven, Connecticut, United States
🇺🇸Kansas City VAMC, Kansas City, Kansas, United States
Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes
- Conditions
- Hereditary Cancer
- Interventions
- Diagnostic Test: Diagnostic Test
- First Posted Date
- 2017-03-16
- Last Posted Date
- 2017-08-08
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 145
- Registration Number
- NCT03081455
- Locations
- 🇺🇸
Westwood Women's Health, Waterbury, Connecticut, United States
🇺🇸Associates for Women's Medicine, Syracuse, New York, United States
Combined Breast Cancer Risk Study
- Conditions
- Hereditary Cancer
- Interventions
- Diagnostic Test: Diagnostic test
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 553
- Registration Number
- NCT03067389
- Locations
- 🇺🇸
The Breast Center of Northwest Arkansas, Fayetteville, Arkansas, United States
🇺🇸Cuda Women's Health Center, Hyannis, Massachusetts, United States
🇺🇸Elizabeth Wende Breast Care, Rochester, New York, United States
Bipolar Proteomic Assay Validation Study
- Conditions
- Major Depressive Disorder, Bipolar I and Bipolar II
- Interventions
- Other: Diagnostic test (LDT)
- First Posted Date
- 2016-04-21
- Last Posted Date
- 2020-05-14
- Lead Sponsor
- Myriad Genetic Laboratories, Inc.
- Target Recruit Count
- 261
- Registration Number
- NCT02746367
- Locations
- 🇺🇸
Lindner Center of HOPE/University of Cincinnati College of Medicine, Mason, Ohio, United States
🇺🇸University of Iowa Health Care, Department of Psychiatry, Iowa City, Iowa, United States
🇺🇸University of Pittsburgh Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States